ArticleCureus2026

Tumor Lysis Syndrome Risk in Burkitt Lymphoma Versus Mantle Cell Lymphoma During Alkylating Therapy: A Propensity-Matched TriNetX Comparative Outcome Analysis.

Anna Homeniuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.